Cipla surged 8.33% to Rs 1,535.50 after the drug maker the US drug regulator classified the manufacturing facility in Goa as voluntary action indicated (VAI).
Subscribe To Our Free Newsletter |
Cipla surged 8.33% to Rs 1,535.50 after the drug maker the US drug regulator classified the manufacturing facility in Goa as voluntary action indicated (VAI).
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!